Skip to content
  • Clinical Trials
  • Our Network
  • Our Story
  • Clinical Trials
  • Our Network
  • Our Story
OnCore Login
  • Clinical Trials
  • Current Trials
  • Publications
  • Our Network
  • Clinical Trial Working Groups
  • Sponsor-Investigators
  • Fostering an Environment of Mentorship
  • Member Sites
  • Partners in Research
  • About
  • Our Story
  • Our Team
  • Annual Reports
  • Services
  • Biorepository & Correlative Services
  • Rapid Accrual
  • Efficient Timelines for Activation
  • Regulatory Compliance
  • Accurate & Relevant Data
  • News & Events
  • HCRN Calendar
  • Oncology Meetings
  • Make a Difference
  • Donate Now
  • Fundraising Events
  • Advocacy Organizations
  • Honor Your Hero
  • Careers
  • Contact
  • OnCore Login

Return to Trial Database

HCRN-GU22-587

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)

Status

Currently Enrolling

Cancer Type(s)

Kidney

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Publications

Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT)
  • M Serzan, O Jegede, R Alter, M Asim Bilen, D Braun, D Einstein, N Haas, H Hammers, D Herchenhorn, J King, K Runcie, J Sosman, C Sternberg, Y Yang, T Choueiri, S Signoretti, MB Atkins

Trial Locations

All sites in which the trial HCRN-GU22-587 being conducted in.
Beth Israel Deaconess Medical Center
Columbia University Irving Medical Center
Dana-Farber Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
John Theurer Cancer Center at Hackensack Meridian Health
Moores Cancer Center at UC San Diego Health
Penn Medicine Abramson Cancer Center
The Ohio State University
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Weill Cornell Medicine
Winship Cancer Institute of Emory University
Yale Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278
  • contact@hoosiercancer.org
  • (317) 921-2050
  • Terms of Use
  • Privacy Policy

Current Trials

Our Network

Our Story